iHuman Inc. Sponsored ADR (NYSE:IH) Sees Large Drop in Short Interest

iHuman Inc. Sponsored ADR (NYSE:IH) was the recipient of a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 4,205 shares, a decline of 46.6% from the April 15th total of 7,876 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 7,975 shares, the short-interest ratio is currently 0.5 days.

iHuman Stock Performance

Shares of NYSE IH remained flat at $1.65 during trading hours on Friday. The company had a trading volume of 4,128 shares, compared to its average volume of 8,377. The stock has a market capitalization of $84.33 million, a PE ratio of 6.60 and a beta of 0.16. iHuman has a 12 month low of $1.55 and a 12 month high of $3.60. The stock has a 50 day moving average price of $1.75 and a 200-day moving average price of $2.06.

iHuman (NYSE:IH) last posted its earnings results on Tuesday, March 31st. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $27.25 million for the quarter. iHuman had a return on equity of 9.79% and a net margin of 11.80%.

iHuman Dividend Announcement

The firm also recently announced an annual dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 17th were paid a $0.10 dividend. The ex-dividend date of this dividend was Friday, April 17th. This represents a dividend yield of 573.0%.

Institutional Trading of iHuman

An institutional investor recently bought a new position in iHuman stock. Acadian Asset Management LLC acquired a new stake in shares of iHuman Inc. Sponsored ADR (NYSE:IH) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 15,067 shares of the company’s stock, valued at approximately $32,000. Hedge funds and other institutional investors own 4.92% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of iHuman in a report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, iHuman currently has a consensus rating of “Sell”.

iHuman Company Profile

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.